Neopenda, PBC
Biotechnology · CHICAGO, IL
BiotechnologySEC Form D
Neopenda, PBC filed a Form D with the U.S. Securities and Exchange Commission on May 7, 2026, reporting $35,000 raised toward a $1,500,000 offering.
Incorporated in Delaware and based in CHICAGO, IL, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Neopenda, PBC has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Sona ShahExecutive Officer · Director
- Teresa CauvelExecutive Officer · Director
- Zachary SeavernsDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised